Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33


Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia.

Sharma ND, Nickl CK, Kang H, Ornatowski W, Brown R, Ness SA, Loh ML, Mullighan CG, Winter SS, Hunger SP, Cannon JL, Matlawska-Wasowska K.

Cancer Sci. 2019 Apr 11. doi: 10.1111/cas.14021. [Epub ahead of print]


Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan.

Chen DQ, Cao G, Chen H, Argyopoulos CP, Yu H, Su W, Chen L, Samuels DC, Zhuang S, Bayliss GP, Zhao S, Yu XY, Vaziri ND, Wang M, Liu D, Mao JR, Ma SX, Zhao J, Zhang Y, Shang YQ, Kang H, Ye F, Cheng XH, Li XR, Zhang L, Meng MX, Guo Y, Zhao YY.

Nat Commun. 2019 Apr 1;10(1):1476. doi: 10.1038/s41467-019-09329-0.


Accurate and efficient estimation of small p-values with the cross-entropy method: applications in genomic data analysis.

Shi Y, Wang M, Shi W, Lee JH, Kang H, Jiang H.

Bioinformatics. 2018 Dec 6. doi: 10.1093/bioinformatics/bty1005. [Epub ahead of print]


Ovarian Tumor Microenvironment Signaling: Convergence on the Rac1 GTPase.

Hudson LG, Gillette JM, Kang H, Rivera MR, Wandinger-Ness A.

Cancers (Basel). 2018 Sep 27;10(10). pii: E358. doi: 10.3390/cancers10100358. Review.


Dysregulated transcriptional networks in KMT2A- and MLLT10-rearranged T-ALL.

Kang H, Sharma ND, Nickl CK, Devidas M, Loh ML, Hunger SP, Dunsmore KP, Winter SS, Matlawska-Wasowska K.

Biomark Res. 2018 Aug 23;6:27. doi: 10.1186/s40364-018-0141-z. eCollection 2018.


Transcriptomes define distinct subgroups of salivary gland adenoid cystic carcinoma with different driver mutations and outcomes.

Frerich CA, Brayer KJ, Painter BM, Kang H, Mitani Y, El-Naggar AK, Ness SA.

Oncotarget. 2017 Dec 23;9(7):7341-7358. doi: 10.18632/oncotarget.23641. eCollection 2018 Jan 26.


Dietary Nutrient Intake, Ethnicity, and Epigenetic Silencing of Lung Cancer Genes Detected in Sputum in New Mexican Smokers.

Leng S, Picchi MA, Kang H, Wu G, Filipczak PT, Juri DE, Zhang X, Gauderman WJ, Gilliland FD, Belinsky SA.

Cancer Prev Res (Phila). 2018 Feb;11(2):93-102. doi: 10.1158/1940-6207.CAPR-17-0196. Epub 2017 Nov 8.


Default Patterning Produces Pan-cortical Glutamatergic and CGE/LGE-like GABAergic Neurons from Human Pluripotent Stem Cells.

Floruta CM, Du R, Kang H, Stein JL, Weick JP.

Stem Cell Reports. 2017 Nov 14;9(5):1463-1476. doi: 10.1016/j.stemcr.2017.09.023. Epub 2017 Oct 26.


Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.

Brayer KJ, Frerich CA, Kang H, Ness SA.

Cancer Discov. 2016 Feb;6(2):176-87. doi: 10.1158/2159-8290.CD-15-0859. Epub 2015 Dec 2.


Gene Expression Studies on Human Trisomy 21 iPSCs and Neurons: Towards Mechanisms Underlying Down's Syndrome and Early Alzheimer's Disease-Like Pathologies.

Weick JP, Kang H, Bonadurer GF 3rd, Bhattacharyya A.

Methods Mol Biol. 2016;1303:247-65. doi: 10.1007/978-1-4939-2627-5_15. Review.


A Novel Pharmacologic Activity of Ketorolac for Therapeutic Benefit in Ovarian Cancer Patients.

Guo Y, Kenney SR, Cook L, Adams SF, Rutledge T, Romero E, Oprea TI, Sklar LA, Bedrick E, Wiggins CL, Kang H, Lomo L, Muller CY, Wandinger-Ness A, Hudson LG.

Clin Cancer Res. 2015 Nov 15;21(22):5064-72. doi: 10.1158/1078-0432.CCR-15-0461. Epub 2015 Jun 12.


Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists.

Mahmoud AZ, George TI, Czuchlewski DR, Zhang QY, Wilson CS, Sever CE, Bakhirev AG, Zhang D, Steidler NL, Reichard KK, Kang H, Foucar K, Vasef MA.

Mod Pathol. 2015 Apr;28(4):545-51. doi: 10.1038/modpathol.2014.140. Epub 2014 Nov 28.


High incidence of ErbB3, ErbB4, and MET expression in ovarian cancer.

Davies S, Holmes A, Lomo L, Steinkamp MP, Kang H, Muller CY, Wilson BS.

Int J Gynecol Pathol. 2014 Jul;33(4):402-10. doi: 10.1097/PGP.0000000000000081.


Narcotic administration and fall-related injury in the hospital: implications for patient safety programs and providers.

Pierce JR Jr, Shirley M, Johnson EF, Kang H.

Int J Risk Saf Med. 2013;25(4):229-34. doi: 10.3233/JRS-130603.


BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.

Swaminathan S, Huang C, Geng H, Chen Z, Harvey R, Kang H, Ng C, Titz B, Hurtz C, Sadiyah MF, Nowak D, Thoennissen GB, Rand V, Graeber TG, Koeffler HP, Carroll WL, Willman CL, Hall AG, Igarashi K, Melnick A, Müschen M.

Nat Med. 2013 Aug;19(8):1014-22. doi: 10.1038/nm.3247. Epub 2013 Jul 14.


Redesign of an internal medicine ward rotation: operational challenges and outcomes.

Pierce JR Jr, Chang B, Rogers KM, Jernigan JR, Fotieo DR, Kang H, Leverence RR.

J Grad Med Educ. 2012 Mar;4(1):97-100. doi: 10.4300/JGME-D-11-00092.1.


Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.

Loh ML, Zhang J, Harvey RC, Roberts K, Payne-Turner D, Kang H, Wu G, Chen X, Becksfort J, Edmonson M, Buetow KH, Carroll WL, Chen IM, Wood B, Borowitz MJ, Devidas M, Gerhard DS, Bowman P, Larsen E, Winick N, Raetz E, Smith M, Downing JR, Willman CL, Mullighan CG, Hunger SP.

Blood. 2013 Jan 17;121(3):485-8. doi: 10.1182/blood-2012-04-422691. Epub 2012 Dec 4.


CD34+ megakaryocytes (≥30%) are associated with megaloblastic anaemia and non-acute myeloid neoplasia.

Insuasti-Beltran G, Steidler NL, Kang H, Reichard KK.

Histopathology. 2012 Oct;61(4):694-701. doi: 10.1111/j.1365-2559.2012.04259.x.


Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.

Chen IM, Harvey RC, Mullighan CG, Gastier-Foster J, Wharton W, Kang H, Borowitz MJ, Camitta BM, Carroll AJ, Devidas M, Pullen DJ, Payne-Turner D, Tasian SK, Reshmi S, Cottrell CE, Reaman GH, Bowman WP, Carroll WL, Loh ML, Winick NJ, Hunger SP, Willman CL.

Blood. 2012 Apr 12;119(15):3512-22. doi: 10.1182/blood-2011-11-394221. Epub 2012 Feb 24.


Identification of a small molecule yeast TORC1 inhibitor with a multiplex screen based on flow cytometry.

Chen J, Young SM, Allen C, Seeber A, Péli-Gulli MP, Panchaud N, Waller A, Ursu O, Yao T, Golden JE, Strouse JJ, Carter MB, Kang H, Bologa CG, Foutz TD, Edwards BS, Peterson BR, Aubé J, Werner-Washburne M, Loewith RJ, De Virgilio C, Sklar LA.

ACS Chem Biol. 2012 Apr 20;7(4):715-22. doi: 10.1021/cb200452r. Epub 2012 Feb 1.

Supplemental Content

Loading ...
Support Center